RecruitingPhase 2

Use of Botulinum Toxin A in Direct Eyebrow Lift Scar

Brazil40 participantsStarted 2024-01-01

Plain-language summary

Prospective, controlled and randomized study in which participants indicated for surgery to direct eyebrow lift will be randomized into two groups. In addition to surgery, the patients will be treated with botulinum toxin in one eyebrow and saline (placebo) in the other site. The patients participate as treatment and placebo at the same time. Assessments will be carried out through non-invasive exams.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients over 18 years of age with indication for direct eyebrow lift surgery. Exclusion Criteria: * Vulnerable groups: children, pregnant women and immunosuppressed patients * Allergy to botulinum toxin A * Patients under 18 years old * Women who are breastfeeding * Patients with muscular/neuromuscular diseases such as myasthenia gravis and amyotrophic lateral sclerosis * Patients who underwent botulinum toxin A injection in the last 6 months prior to surgery * Patients with a history of radiotherapy, chemotherapy or hematological disorders * Refusal to participate in the study

What they're measuring

Scar evaluation 1

Timeframe: One month, three months and six months after surgery

Scar evaluation 2

Timeframe: One month, three months and six months after surgery

Scar evaluation 3

Timeframe: One month, three months and six months after surgery

Scar evaluation 4

Timeframe: One month, three months and six months after surgery

Trial details

NCT IDNCT06465056

SponsorUniversity of Sao Paulo

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-01-01

Contact for this trial

Renata Lemos

(11) 2661-7217 rdinizlemos@gmail.com

View on ClinicalTrials.gov More Skin Scarring trials